FORM 8.3 |
|||||||
IRISH TAKEOVER PANEL |
|||||||
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, |
|||||||
TAKEOVER RULES, 2007 (AS AMENDED) |
|||||||
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES |
|||||||
REPRESENTING 1% OR MORE |
|||||||
1. |
KEY INFORMATION |
||||||
Name of person dealing (Note 1) |
Barclays PLC. |
||||||
Company dealt in |
HORIZON THERAPEUTICS PLC |
||||||
Class of relevant security to which the dealings being disclosed relate (Note 2) |
$0.001 ordinary shares |
||||||
Date of dealing |
06 Oct 2023 |
||||||
2. |
INTERESTS AND SHORT POSITIONS |
||||||
(a) |
Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) |
||||||
Class of relevant security: |
$0.001 ordinary shares |
||||||
|
Long |
Short |
|||||
Number |
(%) |
Number |
(%) |
||||
(1) |
Relevant securities |
126,460 |
0.06% |
58,082 |
0.03% |
||
(2) |
Derivatives (other than options): |
0 |
0.00% |
0 |
0.00% |
||
(3) |
Options and agreements to purchase/sell: |
0 |
0.00% |
0 |
0.00% |
||
TOTAL: |
126,460 |
0.06% |
58,082 |
0.03% |
|||
(b) |
Interests and short positions in relevant securities of the company, other than the class dealt in |
||||||
Class of relevant security: |
Long |
Short |
|||||
Number |
(%) |
Number |
(%) |
||||
(1) |
Relevant securities |
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
||
(3) |
Options and agreements to purchase/sell: |
|
|
|
|
||
TOTAL: |
|
|
|
|
|||
3. |
DEALINGS (Note 4) |
||||||
(a) |
Purchase and sales |
|
|
|
|
|
|
Class of relevant Security |
Purchase/sale |
Number of securities |
Price per unit |
||||
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b) |
Derivatives transactions (other than option transactions) |
||||||
Product Name |
Nature of transaction |
Number of relevant securities |
Price per unit |
||||
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) |
Options transactions in respect of existing securities |
||||||
(i) |
Writing, selling, purchasing or varying |
||||||
Class of relevant security |
Product description |
Writing, purchasing, selling, varying etc |
Number of securities to which option relates |
Exercise price per unit |
Type |
Expiry date |
Option money paid/ received per unit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercising |
|
|
|
|
|
|
Product name |
Number of |
Exercise price |
|||||
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) |
Other dealings (including transactions in respect of new securities) (Note 4) |
||||||
Nature of transaction |
Details |
Price per unit |
|||||
|
|
|
|||||
4. |
OTHER INFORMATION |
||||||
Agreements, arrangements or understandings relating to options or derivatives |
|||||||
Full details of any agreement, arrangement or understanding between the person disclosing |
|||||||
NONE |
|||||||
Is a Supplemental Form 8 (Open Positions) attached? |
NO |
||||||
Date of disclosure: |
09 Oct 2023 |
||||||
Contact name: |
Large Holdings Regulatory Operations |
||||||
Telephone number: |
020 3134 7213 |
||||||
If a connected EFM, name of offeree/offeror with which connected |
|
||||||
If a connected EFM, state nature of connection |
|